Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹685.00
Market cap: ₹7,284 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 53.5×Sector 47.4×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 3 Employee Stock Options 3 Annual General Meeting 3 Other Announcement 2 Capital Structure Change 2 Management Change 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

11 Aug 2026 13:24 IST BSE

Capital Structure Change

Bliss GVS Pharma Capital Structure Change

Life Insurance Corporation of India reduced its stake in Bliss GVS Pharma Ltd by 2.15% via market sale. The institutional investor's holding decreased to 2.96%.

Read the filing ↗

22 Jul 2026 17:13 IST BSE

Capital Structure Change

Bliss GVS Pharma Capital Structure Change

Clarus Trust acquired an additional 0.18% stake in Bliss GVS Pharma via open market purchases, taking their total holding to 5.13%.

Read the filing ↗